ARCHIVES

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

This article is from The Cancer Letter archive.

Vol. 31 No. 30 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009

Colorado Institutions Vying to Build First Carbon Ion Center in the U.S.

September 26, 2014

In Brief: Anti-Smoking Resolution Lost In White House; Pay Bill Defeat Leaves 73 At The Top In NCI

March 22, 1974

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

NCAB Calls For Modification Of Rules For NIH Scientist-Industry Collaboration

December 10, 2010